Alpha lastest QR summary

Based on the financial performance detailed in the document for Alpha IVF Group Berhad for the fourth quarter ended 31 May 2024, here are the key points:

### Financial Performance Summary
1. **Revenue and Profit**:
- The Group recorded a revenue of RM46.75 million for the current financial quarter and RM167.59 million for the current financial period-to-date.
- Profit before taxation (PBT) for the quarter was RM19.42 million, and profit after taxation (PAT) was RM14.31 million.
- For the financial period-to-date, PBT was RM72.01 million, and PAT was RM54.07 million.

2. **Growth and Performance**:
- Revenue increased by 14.86% compared to the immediate preceding quarter, indicating growth in business operations.
- The profit before taxation also saw an increase of 7.83% from the previous quarter.

3. **Equity and Liabilities**:
- Total assets amounted to RM228.26 million as of 31 May 2024, with equity attributable to owners of the company being RM187.43 million.
- The company has a healthy equity-to-total assets ratio, suggesting strong financial stability .

4. **Dividends**:
- The company declared and paid dividends amounting to RM31.38 million for the financial year ended 31 May 2024.

### Conclusion
Alpha IVF Group Berhad has shown robust financial performance with significant growth in revenue and profits, stable equity, and a healthy balance sheet. The company’s consistent revenue growth, profitability, and ability to pay dividends suggest a strong financial position and potential for future growth.

### Investment Worthiness
Considering the financial health and growth prospects of Alpha IVF Group Berhad, it appears to be a sound investment opportunity. However, it is always advisable to consider market conditions, industry trends, and individual financial goals before making an investment decision.